Literature DB >> 3582362

Identification of the intermolecular disulfide bonds of the human transferrin receptor and its lipid-attachment site.

S Q Jing, I S Trowbridge.   

Abstract

Structural studies of the human transferrin receptor have shown that the molecule is a disulfide-bonded dimer consisting of two identical subunits (Mr = 95,000) which are post-translationally modified by the addition of a fatty acyl moiety. Oligonucleotide site-directed mutagenesis has been used to obtain mutant molecules in which each of the four cysteines, residues 62, 67, 89 and 98, clustered within or adjacent to the membrane-spanning region were modified to serine. By first preparing mutants with only one of these cysteine residues modified to serine and then obtaining additional mutants in which different combinations of two cysteine residues were modified, we have shown that both cysteine 89 and cysteine 98, which are located in the extracellular domain of the receptor, are involved in intermolecular disulfide bonds. Further, we have identified cysteine 62 as the major site of acylation. Each of the mutant molecules is synthesized and transported to the cell surface when the modified human transferrin receptor cDNAs are transiently expressed in simian Cos cells. It should therefore now be possible to design experiments to determine whether these modified receptors bind transferrin normally and mediate iron uptake.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582362      PMCID: PMC553399          DOI: 10.1002/j.1460-2075.1987.tb04758.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  24 in total

1.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

2.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

3.  Biosynthesis of the human transferrin receptor in cultured cells.

Authors:  M B Omary; I S Trowbridge
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

4.  Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.

Authors:  I S Trowbridge; F Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9.

Authors:  C Schneider; R Sutherland; R Newman; M Greaves
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

6.  Murine cell surface transferrin receptor: studies with an anti-receptor monoclonal antibody.

Authors:  I S Trowbridge; J Lesley; R Schulte
Journal:  J Cell Physiol       Date:  1982-09       Impact factor: 6.384

7.  The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid.

Authors:  B M Sefton; I S Trowbridge; J A Cooper; E M Scolnick
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

8.  Human cell-surface glycoprotein with unusual properties.

Authors:  M B Omary; I S Trowbridge; J Minowada
Journal:  Nature       Date:  1980-08-28       Impact factor: 49.962

9.  Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin.

Authors:  I S Trowbridge; M B Omary
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Covalent binding of fatty acid to the transferrin receptor in cultured human cells.

Authors:  M B Omary; I S Trowbridge
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  44 in total

1.  Down-regulation of cell surface receptors is modulated by polar residues within the transmembrane domain.

Authors:  L Zaliauskiene; S Kang; C G Brouillette; J Lebowitz; R B Arani; J F Collawn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

Review 2.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  The cytoplasmic tail of invariant chain regulates endosome fusion and morphology.

Authors:  Tommy W Nordeng; Tone F Gregers; Thomas Lasker Kongsvik; Stéphane Méresse; Jean-Pierre Gorvel; Fabrice Jourdan; Andrea Motta; Oddmund Bakke
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

Review 4.  Acylation of viral and eukaryotic proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

5.  Specific heteromeric association of four transmembrane peptides derived from platelet glycoprotein Ib-IX complex.

Authors:  Shi-Zhong Luo; Renhao Li
Journal:  J Mol Biol       Date:  2008-07-22       Impact factor: 5.469

6.  Structural requirements for palmitoylation of surfactant protein C precursor.

Authors:  Anja ten Brinke; Arie B Vaandrager; Henk P Haagsman; Anja N J A Ridder; Lambert M G van Golde; Joseph J Batenburg
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

7.  S-Palmitoylation of Junctional Adhesion Molecule C Regulates Its Tight Junction Localization and Cell Migration.

Authors:  Pornpun Aramsangtienchai; Nicole A Spiegelman; Ji Cao; Hening Lin
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

8.  BRI2 homodimerizes with the involvement of intermolecular disulfide bonds.

Authors:  Maria Tsachaki; Jorge Ghiso; Agueda Rostagno; Spiros Efthimiopoulos
Journal:  Neurobiol Aging       Date:  2008-04-28       Impact factor: 4.673

9.  Comparison of the kinetics of cycling of the transferrin receptor in the presence or absence of bound diferric transferrin.

Authors:  N Gironès; R J Davis
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 10.  Modification of proteins with covalent lipids.

Authors:  E N Olson
Journal:  Prog Lipid Res       Date:  1988       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.